?
DRJ Dent Res J Dental Research Journal Dental Research Journal 1735-3327 2008-0255 Medknow Publications Pvt Ltd India DRJ-11-204 Original Article Detection of oral squamous cell carcinoma metastasis with cathepsin D: An immunohistochemical approach Kapoor Seema Kaur Geet P Sikka Pranav Department of Oral and Maxillofacial Pathology, Sudha Rastogi Dental College, Faridabad, Haryana, India Department of Oral and Maxillofacial Pathology, Sudha Rastogi Dental College, Faridabad, Haryana, India Department of Pharmacology, LLRM Medical College, Meerut, Uttar Pradesh, India Address for correspondence:Seema Kapoor, Department of Oral and Maxillofacial Pathology, Sudha Rastogi Dental College, Faridabad, Haryana, India simu50@yahoo.com Mar–Apr 2014 11 2 204 211 Copyright: © Dental Research Journal 2014

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 Background:

The lysosomal protease cathepsin D (CD) has been associated with tumor progression in malignant tumors including oral squamous cell carcinoma (OSCC). The purpose of this study was to find out any association between the CD and lymph node metastasis and to study the correlation of CD with various clinicopathological parameters to aid in assessment of its role as a prognostic indicator.

 Materials and Methods:

Immunohistochemical staining was performed on 20 OSCC samples with polyclonal antibody against CD. Positive results indicative of the presence of CD were further analyzed to determine any correlation between the CD and other clinicopathological parameters. Pearson Chi-square analyses, Spearsman correlation coefficient, Mann-Whitney test, Kruskal Wallis test and student t test were used for statistical analysis (P < 0.05).

 Results:

Patients with lymph node metastasis showed statistically significant increase in CD expression (P < 0.01). Increasing tumor size seemed to correlate with increased CD expression (P < 0.05).

 Conclusion:

Based on its association with other clinicopathological variables, CD expression can be used for the assessment of patient survival in cases of OSCC.

 Cathepsin D metastasis oral squamous cell carcinoma </sec> <sec> <title>Introduction

Globally, oral squamous cell carcinoma (OSCC) is one of the ten most frequently diagnosed cancers. All the modern treatment modalities have been unable to modify the survival rate of OSCC. The factors that are presently considered to influence prognosis of oral cancers are tumor size, histologic type, and lymph node metastasis. 1 , 2

Malignant tumor cells have a tendency to invade the surrounding matrix and penetrate the basement membrane. Extracellular matrix components comprises of collagens, glycoproteins, proteoglycans, and glycosaminoglycans. Proteases are thought to play an important role in tumor invasion and metastasis because they degrade extracellular matrices and basement membranes. 3 , 4

Aberrant signaling cascades leading to selective over-expression of a number of proteinases cause the highly invasive and metastatic phenotypes of malignant cells. Such proteinases include aspartic proteases (Cathepsin D [CD]), Cysteine proteases (Cathepsin B), Matrix Metalloproteinases (MMP-1, MMP-2, MMP-3, MMP-7, and MMP-9), serine proteinases, and urokinase-type plasminogen activator. 5

Cathepsins are lysosomal endopeptidases, which, in normal cells, participate in the proteolysis of endocytosed proteins and proteolytic activation of secretary proteins. They are powerful inducible proteinases with broad substrate specificity; some of them may be induced by oncoproteins (ras, fos/jun), hormones, and cytokines (interleukin-1, granulocyte-macrophage colony stimulating factor). They play a variety of functions in intracellular processing and metabolism. Secretion and alteration in the subcellular localization of cathepsins in malignant cells is presumed to function in the digestion of the extracellular matrix components. 6 , 7 , 8

CD, a lysosomal acidic protease, was first identified as a 52 kDa estrogen dependent glycoprotein in MCF-7 cells (Michigan Cancer Foundation-7 cells)). Three forms of CD include the 52 kDa procathepsin D (pCD) (enzymatically inactive), an active intermediate form (48 kDa) and mature 34 kDa and 14 kDa dimer form. 9 The mature forms of CD proteolytically degrade extracellular matrices and proteoglycans. 10

In the last decade; however, an increasing number of studies demonstrated that enzymatic function of CD is not restricted solely to its proteolytic action, but also involves regulation of apoptosis along with a significant role in mitogenesis; numerous studies found that pCD/CD level represents an independent prognostic factor in a variety of cancers and is therefore, considered as to be a potential target of anti-cancer therapy. 11 , 12 , 13

The purpose of this study was to find out any association between the CD with lymph node metastasis and to study the correlation of CD with various clinicopathological parameters to aid in assessment of its role as a prognostic indicator.

 Materials and Methods

Sample selection

Twenty primary OSCC specimens were retrieved from Department of Oral and Maxillofacial Pathology of a tertiary care teaching dental hospital of north India. The specimens included previously untreated, surgically resected tumors for which complete clinico-pathological data was available. After reviewing each case, selected paraffin blocks were obtained for tissue sectioning. Clinicopathological information on each case including age, sex, and tumor size, nodal status, tumor grading, and staging was collected. Out of 20 patients, 13 (65%) patients were males and 7 (35%) patients were females. Other patient and tumor characteristics are mentioned in Table 1. Grossly, identified cervical lymph nodes were examined microscopically to classify patients as "node-negative" or "node-positive."{Table 1}

Immunohistochemical (IHC) procedures

Paraffin-embedded sections (5 μm thickness) were deparaffinised and rehydrated, and endogenous paraffin activity was blocked with 3% H 2O 2in methanol. For CD antibody immunostaining (Biogenex), antigen retrieval was achieved by boiling tissue specimens for 5 min at 95°C and 5 min at 98°C in antigen retrieval machine (EZ v.2.1 antigen retriever system) in citrate buffer (pH 6). Staining was performed using standard avidin-biotin method with appropriate secondary antibody. Antibody-reactive sites were visualized with the chromogen substrate diaminobenzidene tetrachloride. Breast cancer specimen was taken as a positive control. Normal mouse or rabbit serum was substituted for monoclonal or polyclonal antibodies. The sections were counterstained lightly with hematoxylin. One section from each sample was stained with hematoxylin and eosin for concurrent histopathologic evaluation.

IHC evaluation of tumor samples

A reproducible semi-quantitative assessment of IHC staining was used to evaluate the expression level of CD in tumor samples. CD expression was measured by examining 100 tumor cells in four randomly selected high power fields. The number of CD positive tumor cells was calculated along with the intensity of staining ranging from 0 to 4. Score (0-4) for CD staining in each tissue section was then calculated by multiplying and proportion of positive cells at each staining intensity by the numerical value of that intensity. The CD expression was graded from 0 to 4 and expression levels of each cathepsin in tumor samples were graded based on the total score as follows: Negative expression = score 0-0.5; low expression = score 0.6-1.0, high expression = score > 1.0.

Malignancy grading of OSCC

H and E sections were graded as well differentiated, moderately differentiated and poorly differentiated OSCC on the basis of Anneroth classification, which included degree of keratinization, nuclear polymorphism, number of mitosis, pattern of invasion, stage of invasion and lymphoplasmocytic infiltration for histologic grading of malignancy of tumor-host relationship. In each case, the lympho-plasmocytic infiltration was graded as marked, moderate, slight or none.

Grading of OSCC

First group without lymph node metastasis included 4 (20%) cases of well-differentiated OSCCs, 3 (15%) cases of moderately differentiated and 3 (15%) cases of poorly differentiated OSCCs, and second group with lymph node metastasis included 10 (50%) cases of well-differentiated OSCCs.

Statistical analysis

The resulting data were analyzed using the SPSS (version 13.0). The distribution of dependent variables was tested using the univariate procedure. Both non-parametric and parametric statistical procedures were used in analyzing data, depending upon variable of interest (i.e., Pearson Chi-square analyses, Spearsman correlation coefficient, Mann-Whitney test, Kruskal Wallis test and student t test).

 Results

CD expression

CD staining was found to be positive in all the cases, although there was a diverse expression with intensity and number of positive cells varying from very low to very high levels. Chief pattern of the staining was paranuclear punctuate type among the differentiated cells at the center of the tumors with the undifferentiated cells at the infiltrating margins, showing diffuse cytoplasmic and cell surface staining. 6 cases (30%) of OSCC showed a low level of CD expression Figure 1and Figure 2, whereas 14 (70%) cases exhibited high levels of CD expression Figure 3and [Figure 4].

Figure 2: Photomicrograph showing extremely focal cathepsin D expression in another case of OSCC without metastasis (cathepsin D immunostaining, original magnification ×40)

Figure 1

Figure 3: Photomicrograph showing a high level of cathepsin D expression in OSCC with metastasis (cathepsin D immunostaining, original magnification ×40)

Figure 2

Figure 4 : Photomicrograph showing a high level and intensity of cathepsin D expression in another case of OSCC with metastasis (cathepsin D immunostaining, original magnification ×40)

Figure 3 {Figure 4}

Comparison of clinico-pathlogical and immuno-histochemical parameters among lymph node positive and negative patients

Sex of the patient and lymph node metastasis were not significantly associated. The cases with lymph node metastasis showed a significantly increased intensity of CD expression (P < 0.05). OSCC with lymph node metastasis showed only slight lymphoplasmocytic infiltration in a highly significant manner (P < 0.001). A significantly increased CD expression was observed in patients with lymph node metastasis (100% cases) compared to patients without lymph node metastasis (P < 0.01) Table 2. Although, the correlation of tumor duration and CD expression with the sex of the patient was not significant, number of CD positive cells was significantly increased in male patients without lymph node metastasis (P < 0.05) Table 3.{Table 2}{Table 3}

Correlation of CD expression with other clinico-pathological variables

No significant association was observed between sex of the patient and other variables such as tumor duration, CD expression, and the number of CD positive cells in any case Table 3. The intensity of CD staining was not significantly related to duration of the tumor and number of CD positive cells in all the cases Table 4. No significant relation could be observed between size of the tumors and other parameters including CD expression and number of CD positive cells in cases without lymph node metastasis. However, increasing CD expression was significantly associated with tumor size in cases with lymph node metastasis Table 5. Furthermore, tumor size did not correlate to the CD intensity, and the number of CD positive cells in SCC Table 5and Table 6. The intensity of CD staining did not correlate with the increasing tumor grading in any case Table 7. The number of CD positive cells and CD expression did not significantly rise with increasing tumor staging Table 8. Although, the correlation between CD expression and intensity of expression to tumor grading was found to be insignificant, number of CD positive cells correlated significantly with increasing tumor grade in squamous cell carcinoma (SCC) without lymph node metastasis (P < 0.05) Table 9. Lymphoplasmocytic infiltration did not correlate with CD positive cells, CD expression, and staining intensity in cases without lymph node metastasis Table 10. No correlation was found between lymphoplasmocytic infiltration and CD staining intensity Table 11.{Table 4}{Table 5}{Table 6}{Table 7}{Table 8}{Table 9}{Table 10}{Table 11}

 Discussion

The goal of this study was to determine whether high levels of CD expression in surgical specimens of oral carcinomas are associated with increased propensity for local invasive growth and lymph node metastasis. Oral carcinomas with high levels of CD expression showed intense cytoplasmic and cell surface staining of tumor cells, most often concentrated at the invasive front of tumors.

In our study, high levels of CD expression was observed in oral carcinomas with regional lymph node metastasis (N1/N2) compared with node-negative tumors (No) (P < 0.05). Moreover, we observed that CD expression also correlated with tumor size in OSCC with lymph node metastasis Table 5. Though, CD expression did not correlate with the stage of the tumor, but the CD positive cells correlated with the tumor grade Table 9.

Spyratos et al. 14 stressed on the role of CD as a prognostic marker for the disease-free interval in patients with breast cancer and emphasized that CD was a more effective prognostic indicator than lymph node metastasis, in the case of lymph node negative patients. The relationship between CD expression and poor survival has been known to differ among lymph node positive and negative patients. 15 , 16

In a study by Henry et al., high levels of CD have been associated with good outcome in breast cancer, 17 whereas high levels of CD have been found both to correlate with aggressive disease and to show no relationship with patient outcome in other studies in node negative patients. 18 , 19

Some of these contradictory findings could be attributed to different methodology used for pCD/CD quantification, subjectivity, different types of tissue, that is fresh versus formalin fixed and paraffin embedded, patients and diagnosis selection, and the length of follow-up period. 8 , 20 , 21

A study by Vigneswaran et al. 22 in oral cancer patients correlated increased expression of CD with the presence of metastasis, poor histologic malignancy grade and high proliferation rate. High levels of CD expresssion have been observed in oral carcinomas with the regional lymph node metastasis compared to node negative tumors. 7 , 8 Increased serum levels of CD has been noted in patients with widespread metastatic carcinoma. 23 , 24

Kawasaki et al. 25 also found that higher CD immunostaining was related to invasion, cell proliferation and to expression of growth factor receptors in OSCC. They also observed that CD had a significant correlation with stage of invasion and lymphoplasmocytic infiltration.

Maurizi et al. 26 found a higher risk of metastatic disease and poor outcome in laryngeal cancer patients with higher expression of CD. A study by Ikeguchi et al. 27 in 154 esophageal SCC patients found that high CD expression was associated with a poor prognosis.

Earlier clinical studies have found pCD/CD related to metastasis-free survival and disease-free survival in breast cancer patient. 14 , 28 Since then, numerous clinical studies have been conducted to find an association between pCD/CD level and tumor size, tumor grade, tumor aggressiveness, incidence of metastasis, prognosis, and a degree of chemoresistance in a variety of solid tumors including head and neck tumors, 20 , 29 , 30 but some of them have given acutely contradictory results. Moreover, studies dealing with pCD/CD diagnostic and prognostic value in cancer are complicated by the fact that there are several forms of CD in a cell at the same time pCD, intermediate enzymatically active CD and mature heavy and light chain CD. Presently some of the researches are also looking for the expression of CD in dysplastic cases, and that could serve as an early attempt for cancer prevention. 31

Conclusion

Patients with lymph node metastasis showed an increase in CD expression, which was statistically significant. Increasing tumor size seemed to correlate with increased CD expression. There was a statistically significant association between increasing number of CD positive cells and increasing grades of OSCC in cases without lymph node metastasis. Furthermore, there was the presence of only slight lymphoplasmocytic infiltration in cases with lymph node metastasis. Thus, based on the active potential of CD in regulating the prognosis of OSCC the design and synthesis of specific CD inhibitors can have significant research and therapeutical consequences. However, standardization of measurement techniques for CD and its other forms is recommended for further clinical usefulness in the field of oncology.

 Shah JP Lydiatt W Treatment of cancer of the head and neck CA Cancer J Clin 1995 45 352 68 Mashberg A Samit AM Early detection, diagnosis, and management of oral and oropharyngeal cancer CA Cancer J Clin 1989 39 67 88 Montcourrier P Mangeat PH Salazar G Morisset M Sahuquet A Rochefort H Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles Cancer Res 1990 50 6045 54 Tryggvason K Höyhtyä M Salo T Proteolytic degradation of extracellular matrix in tumor invasion Biochim Biophys Acta 1987 907 191 217 Mignatti P Rifkin DB Biology and biochemistry of proteinases in tumor invasion Physiol Rev 1993 73 161 95 Ishidoh K Kominami E Gene regulation and extracellular functions of procathepsin L Biol Chem 1998 379 131 5 Frosch BA Berquin I Emmert-Buck MR Moin K Sloane BF Molecular regulation, membrane association and secretion of tumor cathepsin B APMIS 1999 107 28 37 Rochefort H Liaudet-Coopman E Cathepsin D in cancer metastasis: A protease and a ligand APMIS 1999 107 86 95 Capony F Rougeot C Montcourrier P Cavailles V Salazar G Rochefort H Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells Cancer Res 1989 49 3904 9 Rochefort H Biological and clinical significance of cathepsin D in breast cancer Acta Oncol 1992 31 125 30 Vetvicka V Vetvickova J Fusek M Role of procathepsin D activation peptide in prostate cancer growth Prostate 2000 44 1 7 Vetvicka V Vetvickova J Hilgert I Voburka Z Fusek M Analysis of the interaction of procathepsin D activation peptide with breast cancer cells Int J Cancer 1997 73 403 9 Vetvicka V Vetvickova J Fusek M Anti-human procathepsin D activation peptide antibodies inhibit breast cancer development Breast Cancer Res Treat 1999 57 261 9 Spyratos F Maudelonde T Brouillet JP Brunet M Defrenne A Andrieu C Cathepsin D: An independent prognostic factor for metastasis of breast cancer Lancet 1989 2 1115 8 Duffy MJ Reilly D Brouillet JP McDermott EW Faul C O′Higgins N Cathepsin D concentration in breast cancer cytosols: Correlation with disease-free interval and overall survival Clin Chem 1992 38 2114 6 Pujol P Maudelonde T Daures JP Rouanet P Brouillet JP Pujol H A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol Cancer 1993 71 2006 12 Henry JA McCarthy AL Angus B Westley BR May FE Nicholson S Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer.An immunohistochemical study Cancer 1990 65 265 71 Isola J Weitz S Visakorpi T Holli K Shea R Khabbaz N Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer J Clin Oncol 1993 11 36 43 Bevilacqua P Boracchi P Gasparini G Prognostic indicators for early-stage breast-carcinoma.2 Value of cathepsin-d expression, detected by immunocytochemistry - a multiparametric study Prognostic indicators for early-stage breast-carcinoma2 Value of cathepsin-d expression, detected by immunocytochemistry - a multiparametric study Int J Oncol 1994;5:559-64 Leto G Tumminello FM Crescimanno M Flandina C Gebbia N Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications Clin Exp Metastasis 2004 21 91 106 Mirza AN Mirza NQ Vlastos G Singletary SE Prognostic factors in node-negative breast cancer: A review of studies with sample size more than 200 and follow-up more than 5 years Ann Surg 2002 235 10 26 Vigneswaran N Zhao W Dassanayake A Muller S Miller DM Zacharias W Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer Hum Pathol 2000 31 931 7 Hirano T Manabe T Takeguchi S Serum cathepsin B levels and urinary excretion of cathepsin B in the cancer patients with remote metastasis Cancer Lett 1997 79 2132 6 Brouillet JP Dufour F Lemamy G Garcia M Schlup N Grenier J Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay Cancer 1997 79 2132 6 Kawasaki G Kato Y Mizuno A Cathepsin expression in oral squamous cell carcinoma: Relationship with clinicopathologic factors Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002 93 446 54 Maurizi M Almadori G Ferrandina G Distefano M Romanini ME Cadoni G Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma Br J Cancer 1996 74 1253 7 Ikeguchi M Sakatani T Ueta T Fukuda K Oka S Hisamitsu K Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squamous cell carcinoma J Clin Pathol 2002 55 121 6 Thorpe SM Rochefort H Garcia M Freiss G Christensen IJ Khalaf S Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer Cancer Res 1989 49 6008 14 Spyratos F Maudelonde T Brouillet JP Brunet M Defrenne A Andrieu C Cathepsin D: An independent prognostic factor for metastasis of breast cancer Lancet 1989 2 1115 8 Ioachin E Immunohistochemical tumour markers in endometrial carcinoma Eur J Gynaecol Oncol 2005 26 363 71 Cunat S Hoffmann P Pujol P Estrogens and epithelial ovarian cancer Gynecol Oncol 2004 94 25 32